Haemonetics shares details from its first-quarter earnings call for 2027.

Oct 5, 2026, 7:18 AM ETResultsRead the original at Benzinga

Good for HAE

Haemonetics raised its FY2027 sales outlook after sales grew across its business areas. Slower cell-salvage equipment upgrades are a concern, but growth elsewhere makes this update positive for the company.

HAE · Haemonetics Corporation

AI read · Good for HAE

The AI's read

This suggests recent improvements are reaching several parts of the company, rather than relying on one product area. Slower cell-salvage equipment upgrades are the clearest concern. Growth in other business areas and the higher company forecast outweigh that weakness.

Get alerts for HAE

Follow Haemonetics Corporation (HAE) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for HAE

Free on the App Store and Google Play, or on the web.